Back to Search Start Over

PERK activation by CCT020312 chemosensitizes colorectal cancer through inducing apoptosis regulated by ER stress.

Authors :
Lei, Yunpeng
He, Lirui
Yan, Chang
Wang, Yuchen
Lv, Guoqing
Source :
Biochemical & Biophysical Research Communications. Jun2021, Vol. 557, p316-322. 7p.
Publication Year :
2021

Abstract

Endoplasmic reticulum (ER) stress is a significant mechanism for chemoresistance to colorectal cancer (CRC) treatment. The RNA-like endoplasmic reticulum kinase (PERK) is critical for ER stress induction. In the present study, we attempted to explore whether PERK activator CCT020312 (CCT) could be effective for CRC treatment, and reveal the underlying mechanisms. We first found that CCT dose- and time-dependently reduced CRC cell proliferation. Importantly, it markedly improved the chemosensitivity of CRC cells that were drug-sensitive or -resistant to taxol treatment, as evidenced by the significantly decreased cell viability. Moreover, CCT at the non-toxic concentration exhibited obviously synergistic effects with taxol to induce apoptosis and cell cycle arrest in G2/M phase in vitro. In addition, we showed that CCT alone considerably induced ER stress in CRC cells through a dose- and time-dependent fashion. Meanwhile, CCT combined with taxol caused significant ER stress through improving phosphorylated PERK, eukaryotic translation initiation factor 2α (eIF2ɑ), C/EBP homologous protein (CHOP) and glucose-regulated protein 78 (GRP78). More studies showed that the interaction between PERK and GRP78 was a potential target for CCT to perform its regulatory events. Intriguingly, PERK knockdown markedly abolished the regulatory role of CCT and taxol cotreatments in cell proliferation suppression and apoptosis induction, indicating the importance of PERK for CCT to perform its anti-cancer bioactivity. Our in vivo experiments confirmed that CCT plus taxol dramatically reduced tumor growth in CRC xenografts. Together, all these results suggested that promoting PERK activation by CCT may be an effective therapeutic strategy to improve CRC to taxol treatment. • CCT020312 reduces CRC cells proliferation and enhances the suppressive capacity of taxol. • CCT020312 synergistically interacts with taxol to promote apoptosis and induce cell cycle arrest. • CCT020312 induces ER stress in CRC through promoting PERK. • CCT020312-induced apoptosis in CRC is dependent on AKT activation. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
0006291X
Volume :
557
Database :
Academic Search Index
Journal :
Biochemical & Biophysical Research Communications
Publication Type :
Academic Journal
Accession number :
150146343
Full Text :
https://doi.org/10.1016/j.bbrc.2021.03.041